Pharmacy Board of Sierra Leone

What Pharmacy Board of Sierra Leone does

The Pharmacy Board of Sierra Leone is the national government regulatory authority for pharmaceutical products and pharmacy practice in Sierra Leone. Headquartered in Kenema and operating with 11-50 staff, the Board is responsible for drug registration, pharmacy licensing, regulatory inspections, pharmacovigilance, adverse-event monitoring, and quality assurance across the country's pharmaceutical supply chain. Its mandate extends to regulating drug manufacturers, distributors, pharmacies, and healthcare facilities that handle medicines, and it plays a central role in protecting public health through compliance enforcement and workforce development in the pharmaceutical sector. The organization is led by Registrar James Peter Komeh, who represents the Board in international regulatory engagements.

The Board's core "products" are regulatory services — licensing decisions, inspection outcomes, drug registration approvals, and pharmacovigilance oversight — rather than commercial offerings. It does not sell software, devices, or branded products; its technology stack is not publicly disclosed and there is no indication of proprietary digital platforms. As a government state entity, the Board is funded through government appropriations and regulatory fee structures typical of national pharmaceutical regulators, and it does not generate commercial revenue or accept outside investment. There is no disclosed pricing schedule and no parent company, subsidiaries, or venture backing.

In terms of strategic positioning, the Board has actively pursued international regulatory cooperation. In September 2025 it signed a memorandum of understanding with the Egyptian Drug Authority (EDA), chaired by Ali el-Ghamrawy, covering drug registration, pharmaceutical inspections, training programs, and workforce development. A follow-up engagement occurred at Africa Health ExCon 2026 in June 2026, reinforcing bilateral cooperation and continental capacity-building. These moves position the Board within a broader African regulatory network and signal ongoing institutional capacity expansion, though its statutory jurisdiction and operational footprint remain confined to Sierra Leone.

Name

Pharmacy Board of Sierra Leone

Legal name

Pharmacy Board of Sierra Leone

Website

https://pharmacyboard.gov.sl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Pharmacy Board of Sierra Leone is the national government regulatory authority that licenses pharmacies, registers drugs, and conducts pharmaceutical inspections and pharmacovigilance oversight across Sierra Leone, serving pharmaceutical companies, pharmacies, and healthcare facilities under Registrar James Peter Komeh.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Services

NAICS

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (92615)

akta.pro primary industry

Controlled Substances & Pharmacy Regulation Authorities (HLAJACAI)

akta.pro secondary industries

Drug Regulators (Human Pharmaceuticals) (HLAJADAA), Regulatory Compliance, Licensing & Enforcement (Public Health) (HLAJAMAE)

Keywords

• Pharmaceutical regulation
• Pharmacy licensing
• Drug registration
• Pharmacovigilance services
• Pharmacy inspections

Headquarters

HQ city

Kenema

HQ country

Sierra Leone

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Marketing channels1 record

Core offering

The Pharmacy Board of Sierra Leone is the national government regulatory authority for pharmacy practice, responsible for drug registration, pharmacy and premises licensing, pharmaceutical inspections, pharmacovigilance, and safety oversight across Sierra Leone. It enforces compliance with pharmaceutical standards to ensure the safety, efficacy, and quality of medicines distributed in the country. The Board also engages in workforce development and capacity building in pharmaceutical regulation through international partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Registration Services

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Egyptian Drug Authority (EDA)coreStrategic or Co-development Partner · 24 September 2025The Egyptian Drug Authority and Sierra Leone's Pharmacy Board signed a memorandum of understanding to strengthen bilateral cooperation in pharmaceutical regulation. The agreement was signed by EDA Chairman Ali el-Ghamrawy and Sierra Leone Pharmacy Board Registrar James Peter Komeh. The partnership covers drug registration, pharmaceutical inspections, regulatory oversight, training programs, and workforce development. This collaboration supports Egypt's strategy to position itself as a regional hub for pharmaceutical regulation across Africa while enhancing Sierra Leone's regulatory capacity.

Recent moves3 records

Expansion highlights3 records

Others

• African Medicines Agency (AMA): Continental regulatory body being established under the African Union to harmonize medicine regulation across Africa. Comparable in regulatory intent; national regulators like the Pharmacy Board of Sierra Leone will need to align with AMA frameworks.
• World Health Organization (WHO) Prequalification Programme: WHO's prequalification programme assesses medicines, vaccines, and diagnostics for international procurement agencies. Functionally adjacent — it sets the standards African NRAs aspire to align with, and achieving WHO-listed maturity is a benchmark for entities like the Pharmacy Board of Sierra Leone.

Broad incumbents

• National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria: Nigeria's federal regulator for foods, drugs, and other products — the largest pharmaceutical regulator in West Africa and a comparable authority in mandate. Operates at much greater scale than the Sierra Leone Pharmacy Board and is a reference point for West African regional regulatory capacity.
• South African Health Products Regulatory Authority (SAHPRA): South Africa's national health-products regulator, often considered the most mature African NRA. Comparable in core regulatory functions (registration, GMP inspections, pharmacovigilance) but operates at continental scale with WHO-listed maturity.
• Food and Drugs Authority (FDA), Ghana: Ghana's national regulator responsible for food, drugs, cosmetics, and medical devices. Directly comparable in mandate (drug registration, inspections, licensing) and a regional benchmark that West African peers, including Sierra Leone, often align with.

Direct peers

• Egyptian Drug Authority (EDA): Egypt's national pharmaceutical regulator, a direct peer in mandate and the Board's explicit strategic partner under the September 2025 MoU. Comparable in regulatory scope (drug registration, inspections, pharmacovigilance) but at much greater scale.
• Kenya Pharmacy and Poisons Board: Kenya's national pharmacy and poisons regulator — the most directly comparable agency in name, scope, and mandate. Regulates pharmacy practice, drug registration, and inspections at a national level similar to the Pharmacy Board of Sierra Leone.
• Rwanda Food and Drugs Authority (Rwanda FDA): Rwanda's national medicines and food regulator, covering registration, inspections, and pharmacovigilance. A small-state African regulatory peer often cited for fast-tracked regulatory modernization.
• Tanzania Medicines and Medical Devices Authority (TMDA): Tanzania's national medicines and medical devices regulator, responsible for registration, licensing, inspections, and pharmacovigilance. Direct functional peer for the Sierra Leone Pharmacy Board, with comparable African regulatory context.
• National Drug Authority (NDA), Uganda: Uganda's national drug regulator, mandated with drug registration, licensing, and quality control. Comparable in mandate and East/Central African regulatory maturity to the Sierra Leone Pharmacy Board.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/pharmacy-board-of-sierra-leone

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmacy Board of Sierra Leone